Tegaserod In IBS, A Treatment For Irritable Bowel Syndrome

Tegaserod , Zelnorm

Indications: Short term treatment of women with IBS (Constipation predominant) who have failed conventional treatment. WITHDRAWN from women and patients under 65 years of age as possible increase risk of increased cardiovascular events (heart attacks and strokes).

Caution: Withdrawn due to potential cardiovascular events.

Side effects: headache, abdominal pain, diarrhoea (diarrhea), ischaemic colitis, cardiovascular events as outlined.

Adult Dose: 6mg tablet twice a day for 4 to 6 weeks.

Tegaserod in Irritable Bowel Syndrome has been used, but withdrawn on saftey grounds at present.

PLEASE NOTE: Whilst this website has taken every care to make sure the information is correct, we cannot accept any liability for any of the above information. If any concerns, always read the drug manufacturers guidelines or consult a doctor.

For more IBS information


To Return From Tegaserod To The IBS Help Online Homepage Click Here